Skip to main content

Table 3 Final clinico-pathological diagnosis results of the all studied nodular lesions (no. = 200)

From: Impact of lung-RADS classification system on the accurate diagnosis of pulmonary nodular lesions in oncology patients

Final lesion clinical/pathology diagnosis

 

No.

Percent %

Group I: Benign lesions

 

78

39%

 a) Ground glass nodules

26/0

26

13%

 b) Pre-fissural nodules

17/0

17

8.5%

 c) Inflammatory nodules

13/0

13

6.5%

 d) Follow-up static small nodules

10/0

10

5%

 e) Fat/calcifications containing nodules

12/0

12

6%

Group II; Malignant lesions

 

122

61%

 a) Metastatic nodules

19/78

87

43.5%

 b) Sequamus cell carcinoma

0/19

19

9.5%

 c) Adeno-carcinoma

0/7

7

3.5%

 d) Alveolar lung cancer

0/6

6

3%

 e) Small cell carcinoma

0/3

3

1.5%

Total

 

200

100%